Hemab Therapeutics Holdings, Inc. (COAG)
$30.39-3.89%Close
SELL
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $61M
- Beta
- 1.85
- P/E (TTM)
- -21.66
- Short % float
- 646.84%
- Days to cover
- 4.2
- SI change
- +28.4%
- 1W
- -0.65%
- 1M
- -22.87%
- vs SPY 1W
- -1.08%
- vs SPY 1M
- -24.93%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on COAG?
- LOPJLB’s latest quantitative signal on Hemab Therapeutics Holdings, Inc. Common Stock (COAG) is SELL. Signals are updated daily.
- What market regime is COAG in?
- LOPJLB classifies each ticker into BULL, RECOVERY, BEAR, or CRISIS regimes using a Hidden Markov Model.
- What does Hemab Therapeutics Holdings, Inc. Common Stock (COAG) do?
- Hemab Therapeutics Holdings, Inc. is a clinical-stage biotechnology firm dedicated to transforming the treatment of blood coagulation disorders. Operating in the United States and Denmark, its mission is to enhance life and resilience for patients through innovative therapies. The company's leading pipeline candidate is HMB-001, a bispecific antibody. This asset is currently undergoing Phase 1/…